| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 42385-934-12 | 42385-934 | HUMAN PRESCRIPTION DRUG | Lopinavir and Ritonavir | Lopinavir and Ritonavir | TABLET, FILM COATED | ORAL | 20220322 | N/A | ANDA | ANDA213857 | Laurus Labs Limited | LOPINAVIR; RITONAVIR | 200 mg/1; 50 mg/1 | 120 TABLET, FILM COATED in 1 BOTTLE (42385-934-12) |
| 68071-2949-2 | 68071-2949 | HUMAN PRESCRIPTION DRUG | Lopinavir and Ritonavir | Lopinavir and Ritonavir | TABLET, FILM COATED | ORAL | 20230306 | N/A | ANDA | ANDA213857 | NuCare Pharmaceuticals,Inc. | LOPINAVIR; RITONAVIR | 200 mg/1; 50 mg/1 | 12 TABLET, FILM COATED in 1 BOTTLE (68071-2949-2) |
| 42385-933-60 | 42385-933 | HUMAN PRESCRIPTION DRUG | Lopinavir and Ritonavir | Lopinavir and Ritonavir | TABLET, FILM COATED | ORAL | 20220322 | N/A | ANDA | ANDA213857 | Laurus Labs Limited | LOPINAVIR; RITONAVIR | 100 mg/1; 25 mg/1 | 60 TABLET, FILM COATED in 1 BOTTLE (42385-933-60) |